Search for: "Teva Pharmaceuticals" Results 301 - 320 of 1,422
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
24 Mar 2011, 3:40 pm by Brian Baxter
.'s $409 million purchase of Drugstore.com, while Jones Day and Willkie Farr have roles on a joint venture under which Procter & Gamble and Teva Pharmaceuticals will market over-the-counter medicines. [read post]
24 Sep 2007, 8:57 pm
Teva Pharmaceuticals USA Inc. 1:07-cv-00552; filed September 14, 2007 in the District Court of Delaware... [read post]
18 Apr 2011, 2:13 pm by Ronald V. Miller, Jr.
The FDA warned consumers about the generic acid reflux drug Lansoprazole made by Teva Pharmaceutical Industries when the drug is administered by oral syringe or feeding tube. [read post]
4 Dec 2018, 11:16 am by Andrew Hamm
Teva Pharmaceuticals USA Inc. is also available. [read post]
4 May 2008, 8:42 pm
Teva Pharmaceuticals USA Inc. 1:08-cv-00237; filed April 25, 2008 in the District Court of... [read post]
21 Jan 2015, 10:00 pm by Courtenay C. Brinckerhoff
On January 20, 2015, the Supreme Court issued its decision in Teva Pharmaceuticals USA, Inc. v. [read post]
8 Sep 2010, 9:24 am by Mark Zamora
Teva made the drug and Baxter distributed it according to the lawsuit. [read post]
25 Aug 2018, 9:09 pm by Patent Docs
Teva Pharmaceuticals decision holding that the defense of tribal sovereign immunity does not apply to IPR proceedings; • Assessing the latest decisions on § 101 and their implications for branded pharmaceuticals; • Reviewing the state... [read post]
15 Oct 2014, 11:52 am
Supreme Court oral argument in Teva Pharmaceuticals USA, Inc. v. [read post]
28 May 2017, 8:19 pm by Patent Docs
Biosig Instruments, Inc. and Teva Pharmaceuticals USA, Inc. v. [read post]
18 Oct 2018, 9:59 pm by Patent Docs
Teva Pharmaceuticals International GmbH PTAB Petition: IPR2018-01710; filed September 28, 2018. [read post]
21 Nov 2008, 5:49 am
" The 12-page paper, entitled "Proper Duration of Data Exclusivity for Generic Biologics: A Critique," was funded by Teva Pharmaceuticals (see Teva press release), which also funded a report on data exclusivity released last September (see "BU Economics Professor... [read post]
18 Nov 2010, 9:11 pm by Patent Docs
By James DeGiulio -- Otsuka Abilify Patent Found Valid and Enforceable Otsuka Pharmaceutical Co. won a key court ruling that upheld its patent covering Abilify, thereby preventing Teva, Apotex, and Sandoz from releasing generic versions of the drug until April 2015. [read post]
2 May 2011, 4:28 am by By CHRIS V. NICHOLSON
The deal for the biopharmaceutical company comes just weeks after Cephalon rejected a $5.7 billion takeover bid from Valeant Pharmaceuticals. [read post]
1 Oct 2007, 1:45 am
Reddy's Laboratories and Teva Pharmaceutical Industries had argued that Lilly's patent was no longer valid because discovery of Zyprexa's molecular structure was covered by a previous Lilly patent.Separately:Several states are suing Lilly, claiming it marketed Zyprexa for off-label uses, including treatment of dementia, depression and autism, without warning about its risks.Alsohttp://ipbiz.blogspot.com/2006/12/lillys-zyprexa-patent-upheld-at-cafc.html [read post]
19 Aug 2010, 9:55 pm by Patent Docs
By James DeGiulio -- Lilly's Patent for Strattera Found Invalid, Lilly Appeals to Federal Circuit Teva Pharmaceuticals USA, Mylan Pharmaceuticals, and Apotex successfully argued that Eli Lilly's patent for the ADHD drug Strattera (U.S. [read post]